drugset / Trial / NCT06285799
Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Iron Hydroxide Adipate Tartrate (IHAT) at 2 different dose levels compared to placebo for increasing serum ferritin levels in iron deficient, but otherwise healthy premenopausal women over 12 weeks.
Timeline
- Start
- 2024-03-05
- Primary completion
- 2025-02-11
- Completion
- 2025-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Low Dose IHAT | Unknown | 100 mg | Oral |
| Subject | Low Dose IHAT | Unknown | 200 mg | Oral |